The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 2
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- 10.1210/endo.133.2.8344205 · doi:10.1210/endo.133.2.8344205 · Paper page
Cited by
Items 301–400 of 654
Petersen, J. M., Esposito, D. B., & Werler, M. M. (2020) · Archives of Women s Mental Health · doi:10.1007/s00737-020-01027-x · Cited by 11
Microbiome‐gut‐brain axis as a novel hotspot in depression
Ma, Y., Xu, P., Bai, Z., & Fang, J. (2024) · Brain‐X · doi:10.1002/brx2.43 · Cited by 11
Cohen, S. E., Storosum, B. W. C., Zantvoord, J. B., Mattila, T., de Boer, A., & Denys, D. A. J. P. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.87 · Cited by 10
The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer
Dou, J., Jiang, J., Xue, Y., Jiang, X., Jiang, Y., Xiao, P., & Xu, J. (2025) · MedComm · doi:10.1002/mco2.70249 · Cited by 10
Erwartungseffekte beim Absetzen von Antidepressiva: Implikationen für die Praxis
Nestoriuc, Y. (2022) · Psychotherapeut · doi:10.1007/s00278-022-00587-w · Cited by 10
Coutts‐Bain, D., Sharpe, L., Techakesari, P., Forrester, M., & Hunt, C. J. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102342 · Cited by 11
Kwak, H.-Y., Leem, J., Seung, H.-B., Kwon, C., Jeong, H.-S., & Kim, S.-H. (2023) · Healthcare · doi:10.3390/healthcare11222957 · Cited by 10
Mușat, M. I., Militaru, F., Udriștoiu, I., Mitran, S. I., & Cătălin, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092723 · Cited by 14
Use of vortioxetine in different neurological fields: a systematic review and future perspectives
Verrienti, G., Colonna, I., & Raccagni, C. (2025) · Neurological Sciences · doi:10.1007/s10072-025-07987-1 · Cited by 9
Ghaffari, S., Ghobadi, A., Jamshidi, A. H., Mortazavi, S. H., Naderi, S., Aqamolaei, A., Mortezaei, A., Sahebolzamani, E., Shamabadi, A., Jalilvand, S., et al. (2019) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2019.12.002 · Cited by 10
Psychophysiological responses to group cognitive-behavioral therapy in depressive patients
Varela, Y. M., de Almeida, R. N., Galvão, A. C. D. M., de Sousa, G. M., de Lima, A. C. L., da Silva, N. G., Leocádio-Miguel, M. A., Soares, B. L., Hallak, J. E. C., Maia‐de‐Oliveira, J. P., et al. (2021) · Current Psychology · doi:10.1007/s12144-020-01324-9 · Cited by 11
Lu, W., Zhang, H., Zhou, R., Ding, L., Wang, Y., Su, Y., Wang, X., Chen, J., Wu, B., Shen, H., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.071 · Cited by 10
Effect of maternal fluoxetine exposure on lung, heart, and kidney development in rat neonates.
Ghavamabadi, R. T., Taghipour, Z., Hassanipour, M., Khademi, M., & Shariati, M. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2018.27203.6650 · Cited by 9
St‐Amour, S., Hains-Monfette, G., Dancause, K. N., Cailhol, L., & Bernard, P. (2021) · Mental health and physical activity · doi:10.1016/j.mhpa.2021.100394 · Cited by 11
Medical Complications of Psychiatric Treatment
Lahijani, S. C., & Harris, K. A. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.008 · Cited by 8
Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Mareti, Ε., Ampatzi, C., Paschou, S. Α., Voziki, E., & Goulis, D. G. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180911104942 · Cited by 9
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00664-z · Cited by 12
Research status and trends of physical activity on depression or anxiety: a bibliometric analysis
Zhang, X., Ye, F., Yin, Z., Li, Y., Bao, Q.-N., Xia, M., Chen, Z., Zhong, W., Wu, K., Yao, J., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1337739 · Cited by 11
Dou, Y., Yang, X., Du, Y., Cui, W., Luo, Y., Wei, J., Zhao, L., Cai, X., Ma, X., & Lin, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152031 · Cited by 8
ProMENDA: an updated resource for proteomic and metabolomic characterization in depression
Pu, J., Yu, Y., Liu, Y., Wang, D., Gui, S., Zhong, X., Chen, W., Chen, X., Chen, Y., Chen, X., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02948-2 · Cited by 12
Yang, W., Wang, Y., Li, X., Jing, R., Mu, L.-H., & Hu, Y. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111126 · Cited by 8
In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants
Don, C. G., & Smieško, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00683 · Cited by 8
Recent Developments in Pharmacotherapy of Depression: Bench to Bedside
Shad, M. U. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050773 · Cited by 11
Gündüz, G. U., Yener, N. P., Kılınçel, O., & Gündüz, C. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0133 · Cited by 8
Steinke, E. E., Mosack, V., & Hill, T. J. (2018) · Issues in Mental Health Nursing · doi:10.1080/01612840.2017.1413463 · Cited by 8
Time to rethink the approach to recurrent depression
Fava, G. A. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30128-7 · Cited by 8
Self-citationRicketts, E. J., Rozenman, M. S., Snorrason, Í., Perez, J. B., Peng, M. G., Kim, J., & Piacentini, J. C. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.022 · Cited by 8
The Emerging Role of Clinical Pharmacopsychology
Cosci, F., Guidi, J., Tomba, E., & Fava, G. A. (2019) · Clinical Psychology in Europe · doi:10.32872/cpe.v1i2.32158 · Cited by 9
Self-citationDonig, A., & Hautzinger, M. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1888205 · Cited by 9
Berardelli, I., Rogante, E., Formica, F., Iannazzo, R., mammoliti, A. V., Riccioni, R., Veizi, S., McIntyre, R. S., & Pompili, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811241309612 · Cited by 8
Wen, S., Yan, Y., Shao, J., Xie, H., Wang, M., Dou, Y., Liu, D., Xiao, Y., & Ma, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03751-3 · Cited by 7
Saayman, J. L. B., Harvey, B. H., Wegener, G., & Brink, C. B. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176434 · Cited by 9
Association between bowel movement disorders and depressive symptoms: a cross-sectional study
Wang, L., Tian, M., Sun, H., Gao, J., Qi, W., Xu, J., An, Y., & Xu, W. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1449948 · Cited by 9
Tao, L., Yao, C., Wang, S., Ye, Y.-M., Tu, Z., Jiang, X., Xu, L., Shan, L., Liu, Z., & Yu, P. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117941 · Cited by 7
Zou, Z., Xiao, N., Chen, Z., Lin, X., Li, Y., Li, P., Cheng, Q., & Du, B. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300467 · Cited by 9
Agomelatine for postpartum depression and breastfeeding
Xiao, L. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211022172 · Cited by 7
A Retrospective Cross-sectional Study on the Risk Factors of Recurrent Falls Among Inpatients
Chang, W., Jen, H., & Huang, T. (2021) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000585 · Cited by 7
de Viñaspre‐Hernández, R. R., Santolalla‐Arnedo, I., Garrido-Santamaría, R., Czapla, M., Tejada-Garrido, C. I., González, J. L. S., Sapiña-Beltrán, E., Iriarte-Moreda, V. M., Tello, M., Gea-Caballero, V., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092320 · Cited by 9
Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
Gao, M., Ma, H., Liu, T., Cao, C., Zhiyong, Z., Tang, L., Gu, W., Zhang, D., & Sun, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14026 · Cited by 7
Rethinking the medication management of major depression
Mann, J. J., & Rizk, M. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2190886 · Cited by 10
Tu, M., Wu, X., Qu, S., Jin, J., Chen, N., Xiong, S., Pei, S., Li, X., Shi, Y., Hu, H., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183127 · Cited by 7
Zhang, C., Hou, B., Xu, Y., Zeng, S., Luo, X., & Zhang, B. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.055 · Cited by 8
Singh, P., Agrawal, P., & Singh, K. P. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115128 · Cited by 8
Talas, A., Cerit, C., & Aslan, E. A. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1490096 · Cited by 7
Tang, M., & Li, X. (2020) · Zhongnan Daxue xuebao. Yixue ban · doi:10.11817/j.issn.1672-7347.2020.190160 · Cited by 9
Role of vortioxetine in the treatment of neuropathic pain
Montero, A. A., & de Vasconcelos, S. R. P. (2022) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2022.09.003 · Cited by 9
Serious dermatological adverse effects of vortioxetine: two cases
Çetin, M., & Köse, S. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1484013 · Cited by 7
Predictors of recurrence in a sample of 508 outpatients with major depressive disorder
Serafini, G., Santi, F., Gonda, X., Aguglia, A., Fiorillo, A., Pompili, M., Carvalho, A. F., & Amore, M. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.015 · Cited by 6
Self-citationThe central role of mitochondrial dysfunction in neurodegeneration: implications for therapy
Raafat, M. A., Al-Hasnaawei, S., Mousa, H. M., Hanumanthayya, M., Sahoo, S., Prathiba, S., Singh, G., & Sinha, A. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05542-w · Cited by 6
Winder, B., Norman, C., Hamilton, J., Cass, S., Lambert, A., Tovey, L., Hocken, K., Marshall, E., Lievesley, R., Hamilton, L., et al. (2024) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789949.2024.2338917 · Cited by 9
Chen, C., Du, S., Shao, Q., Fu, X., Lin, J., Zhou, S. L., & Li, Y. (2024) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2024.10.068 · Cited by 10
Liu, S., Li, H., Zhang, Y., Gong, K., & Fang, L. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106435 · Cited by 7
Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway
Pan, Y., Huang, Q., Liang, Y., Xie, Y., Tan, F., & Long, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1529566 · Cited by 7
Depression and Heart Failure Assessment, Treatment, and Interventions to Improve Self-Care Behaviors
Wick, L. L. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.02.005 · Cited by 7
Arıkan, M. K., İlhan, R., Pogarell, O. M., & Metin, B. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.024 · Cited by 6
Szlejf, C., Suemoto, C. K., Goulart, A. C., Santos, I. S., Bacchi, P. S., Fatori, D., Razza, L. B., Viana, M. C., Lotufo, P. A., Benseñor, I. M., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.028 · Cited by 6
Self-citationTrazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability
Goldberg, J. F., Steinman, M. Q., & Stahl, S. M. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101127 · Cited by 7
Fatal Cerebral Edema, Seizures, and Hyponatremia After Trazodone Overdose
Avila, J. D. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000235 · Cited by 6
Nebenwirkungen von Psychopharmaka: Tipps für die Praxis
Grunze, A., Mago, R., & Grunze, H. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-110654 · Cited by 8
Interactions of antidepressants, mood-stabilisers and antipsychotics with food
Wasik, A., Krupa, A. J., & Siwek, M. (2019) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2019.04.002 · Cited by 9
Hengartner, M. P., Neuner‐Jehle, S., & Senn, O. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01621-7 · Cited by 7
Asmar, K. E., Fève, B., Colle, R., Gressier, F., Vievard, A., Trabado, S., Verstuyft, C., Haffen, É., Polosan, M., Ferreri, F., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.059 · Cited by 8
Review of selective serotonin reuptake inhibitors
Chigome, A., Matsangaise, M. M., Chukwu, B. O., Matlala, M., Sibanda, M., & Meyer, J. C. (2017) · Pharmacy management · Cited by 6
Faghihi, A., Zanjani, Z., Omidi, A., & Fakharian, E. (2022) · Asian Journal of Social Health and Behavior · doi:10.4103/shb.shb_19_22 · Cited by 5
Wang, S., Zhang, L., Wu, Y., & Ma, J. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s494619 · Cited by 5
Du, R., Zhao, S., Zhang, X., Li, W., Ma, Y., Zhang, Y., Zhang, Z., Yu, Y., Wang, Y., Yang, K., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120303 · Cited by 5
Cui, Y., Ursuliak, Z., & Rupasinghe, H. P. V. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111567 · Cited by 7
Merlo, G., Sugden, S. G., Rosenfeld, R. M., Baron, D. A., Karlsen, M. C., Keyes, S., McHugh, J., Miller, L. A., Nemeroff, C. B., Ramas, M.-E., et al. (2026) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251408353 · Cited by 8
Li, S., Feng, J., & Zhang, S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121336 · Cited by 5
Kahn, B., Boazak, M., Ragazino, J., Sineath, R. C., & Kapral, T. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20180007 · Cited by 5
Zheng, M., Yang, X., Yuan, P., Wang, F., Guo, X., Li, L., Wang, J., Miao, S., Shi, X., & Ma, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2297816 · Cited by 5
Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants
Westphal, L., Gräf, D. D., Le, H., Hallgreen, C. E., & Andersen, M. T. (2025) · Drug Safety · doi:10.1007/s40264-025-01631-9 · Cited by 5
What is the threshold for a clinical minimally important drug effect?
Hengartner, M. P. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-111056 · Cited by 5
Masuka, J. T., Mchunu, N. N., Mkhize, Z., Thandar, Y., & Mosam, A. (2021) · Australasian Journal of Dermatology · doi:10.1111/ajd.13780 · Cited by 5
An update on pharmacotherapy for recurrent depression in 2022
Belge, J.-B., Sabbe, A. C. F., & Sabbe, B. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2223962 · Cited by 7
Sexual dysfunction, depression, and marital adjustment in diabetic male patients
Rathod, A. D., Sawant, N., & Bandgar, T. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_293_24 · Cited by 6
Wu, Y., Cai, J., Liu, H., Li, C., Tang, Q., & Zhang, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17121637 · Cited by 7
Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy
Ćurković, M., Košec, A., & Savić, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00143 · Cited by 6
Wu, Z., Chen, L., Guo, Z., Li, K., Fu, Y., Zhu, J., Chen, X., Huang, C., Zheng, C., Ma, Y., et al. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.06.009 · Cited by 6
The psychopharmacology of brain vascular disease/poststroke depression
Jones, M. B., Corcoran, A., & Jorge, R. E. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00013-7 · Cited by 6
Psychotropic medicines: increased appetite rather than weight gain
Tondo, L., & Baldessarini, R. J. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00500-9 · Cited by 5
L’utilisation des antidépresseurs dans l’épisode dépressif caractérisé unipolaire du sujet âgé
Péricaud, A., Straczek, C., Montastruc, F., Leboyer, M., Yrondi, A., & Arbus, C. (2022) · L Encéphale · doi:10.1016/j.encep.2021.11.006 · Cited by 11
Seifert, J., Bleich, S., & Seifert, R. (2022) · Springer eBooks · doi:10.1007/978-3-662-66303-5_22 · Cited by 6
Duodenojejunal inflammation causing chronic vomiting in adult-onset Still’s disease
Manzotti, C., Castellani, M., Murgo, A., & Basilisco, G. (2023) · BMJ Case Reports · doi:10.1136/bcr-2022-252345 · Cited by 5
Escitalopram-induced epistaxis: A case report
Aljhani, S. (2021) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2021.06.004 · Cited by 5
Breeden, M. A., Gillis, A., Salas, J., & Scherrer, J. F. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110692 · Cited by 6
Starčević, V. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418818362 · Cited by 5
Hess, C. W., Karter, J. M., Cosgrove, L., & Hayden, L. A. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/iby092 · Cited by 6
Jha, A. (2022) · Journal of Psychiatrists Association of Nepal · doi:10.3126/jpan.v11i2.57634 · Cited by 4
Multi-omics analysis reveals the mechanism of action of Atractylodin against depression
Bao, S., Feng, M., Zhang, X., Xie, M., & Jing, T. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-025-01930-6 · Cited by 4
Yu, Q., Yao, J., Li, E., Xia, M., Hu, Z., Xiao, Y., Huang, J., & Lei, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1644241 · Cited by 7
Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways
Lin, R., Zhou, Z., Jiang, Y., Liu, S., Xie, J., Wang, H., Ulrich, H., & Zheng, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1642167 · Cited by 4
Cai, D.-B., Ying-yan, D. E. N. G., Tang, Y.-Y., Qin, X., Deng, C.-J., Lu, Q., Lan, X.-C., Wang, J.-J., Huang, X., & Yang, X.-H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03447-w · Cited by 5
Harini, K., Durgadevi, P., Girigoswami, K., & Girigoswami, A. (2025) · Biomedical Research and Therapy · doi:10.15419/z5q8dv72 · Cited by 4
Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
PANEK, E., JASŁOWSKI, D., RZESZUTKO, M., Raczkiewicz, P., Panasiuk, D., SKRĘTOWICZ, M., SZPONAROWICZ, P., SNOPKOWSKI, B., Korzec, T., & Sosnowski, J. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.19.01.007 · Cited by 4
Molecular and Cellular Mechanisms of Neuropathic Pain in Aging
Huang, H., Wu, J., Chang, Y., Wang, H., Tian, Y., Chen, Z., Feng, J., & Wang, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00010 · Cited by 5
Zhang, J., Zhang, R., Peng, Y. H., Aa, J., & Wang, G. (2023) · Brain Sciences · doi:10.3390/brainsci13050763 · Cited by 5
Seung, H.-B., Kwon, H.-J., Kwon, C., & Kim, S.-H. (2023) · Pharmaceuticals · doi:10.3390/ph16081176 · Cited by 6
Kowalczyk, E., Borysowski, J., Ordak, M., Kniotek, M., Radziwoń-Zaleska, M., & Siwek, M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115730 · Cited by 4
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.